Japan formally approved its first COVID-19 vaccine and said it would start nationwide inoculations within days, but months behind the U.S. and many other countries.
By Mari Yamaguchi, Associated Press
The Pentagon committed to sending around 1,000 active duty troops to help vaccinate people across the nation after the White House promised to open community vaccination centers, increasing availability to those in need. Dr. Julie Morita, Executive Vice President of…
By PBS NewsHour
A U.N.-backed program to deploy COVID-19 vaccines to the neediest people worldwide has announced plans for an initial distribution of some 100 million doses by the end of March.
By Jamey Keaten, Associated Press
President Biden has set a goal to vaccinate 100 million Americans in his first 100 days even as federal and state officials grapple with logistical challenges and the absence of a national inoculation plan. ProPublica reporter Caroline Chen joins Hari…
By PBS NewsHour
By Jill Lawless, Associated Press
A major British doctors’ group says the U.K. government should “urgently review” its decision to give people a second dose of the Pfizer-BioNTech coronavirus vaccine up to 12 weeks after the first, rather than the shorter gap recommended by the…
By Ilan Ben Zion, Associated Press
Israel has struck a deal with Pfizer, promising to share vast troves of medical data with the international drug giant in exchange for the continued flow of its hard-to-get vaccine.
With daily cases crossing 250,000, COVID-19 has killed nearly 380,000 people in the U.S. -- the highest in the world. As states roll out vaccines in phases amid reports of the two more transmissible variants from the UK and South…
By Associated Press
New research suggests the COVID-19 vaccine made by Pfizer and BioNTech can still work against a mutated coronavirus.
By Aniruddha Ghosal, Sheikh Saaliq, Associated Press
The country's drugs regulator gave emergency authorization for the vaccine developed by Oxford University and U.K.-based drugmaker AstraZeneca, and another developed by the Indian company Bharat Biotech.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.